Jared Gollob, Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR), sold 1,298 shares at $30.88 ($40K) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Scheduled sale ($40k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.88 | 1,001 | $31K | 76.8% |
| 2 | $31.40 | 297 | $9K | 23.2% |
| Total | $31.00 avg | 1,298 | $40K | 100% |
| Filing → |
| KYMR | SELL | 2025-10-15 | $7.3M | — | Filing → |
| KYMR | SELL | 2025-10-14 | $187K | — | Filing → |
| KYMR | SELL | 2025-03-03 | $317K | — | Filing → |